Manufacturer:

Fresenius Kabi

Name:

GEMCITABINE

Category:

J Code

HCPCS:

J9201

NDC(s):

00143-9394-01, 00409-0181-25, 00409-0182-25, 00409-0183-25, 00409-0185-01, 00409-0186-01, 00409-0187-01, 16714-0909-01, 16714-0930-01, 16729-0092-03, 16729-0118-38, 16729-0391-30, 16729-0419-03, 16729-0423-33, 16729-0426-05, 23155-0213-31, 23155-0214-31, 23155-0483-31, 23155-0484-31, 23155-0528-31, 23155-0529-31, 25021-0234-10, 25021-0235-50, 25021-0239-05, 25021-0239-26, 25021-0239-52, 47335-0153-40, 47335-0154-40, 55111-0686-07, 55111-0687-25, 60505-6113-06, 60505-6114-00, 60505-6115-02, 63323-0102-13, 63323-0102-94, 63323-0125-53, 63323-0125-94, 63323-0126-03, 67457-0462-01, 67457-0464-20, 67457-0616-10, 67457-0617-30, 67457-0618-10, 68001-0282-26, 68001-0342-34, 68001-0348-36, 68001-0359-37, 70860-0205-50, 71288-0117-06, 71288-0117-28, 71288-0117-54, 00409-0183-01, 00409-0181-01, 00409-0182-01, 63323-0126-00,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

GEMCITABINE is a Cancer drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J9201 is aligned to the drug GEMCITABINE.